In the United States, orthopedics sales were up 13.4 percent to $873 million and international orthopedics sales were up 8 percent to $755 million. The company’s recent acquisition of Synthes contributed 2.9 percent to overall worldwide operational sales growth. Earlier this year, Johnson & Johnson acquired Synthes for $19.7 billion in cash and stock. As part of the transaction, the company agreed to sell its trauma business to Biomet.
More Articles on Johnson & Johnson:
Biomet Closes DePuy Trauma Acquisition
FTC Approves Johnson & Johnson’s $21.3B Acquisition of Synthes
Former Stryker CEO Stephen MacMillan Seeking Johnson & Johnson Position
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.